Cercare Receives FDA Clearance for CBCT Perfusion and Collaborates With Siemens on Acute Stroke Care
Cercare Medical, a developer of neuroimaging software, announced FDA 510(k) clearance for the company’s Cone-Beam CT Perfusio ...
CT perfusion and angiography failed to meet sensitivity and specificity thresholds to determine brain death. Neither should be used as standalone tests to establish death by neurologic criteria, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results